Results 151 to 160 of about 435,266 (312)

Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years

Harm Reduction Journal
Background Consistent reports from health professionals suggest that heroin is commonly used by patients undergoing opioid maintenance treatment (OMT) in France, potentially jeopardizing their recovery process.
Eric Janssen, Mike Vuolo, Stanislas Spilka, Guillaume Airagnes   +3 more
doaj   +1 more source

Linking drug and food addiction via compulsive appetite [PDF]

, 2022
Amanda Laque, Grant E. Wagner, Alessandra Matzeu, Genna L. De Ness, Tony M. Kerr, Ayla Carroll, Giordano de Guglielmo, Hermina Nedelescu, Matthew W. Buczynski, Ann M. Gregus, Thomas C. Jhou, Eric P. Zorrilla, Rémi Martin‐Fardon, Eisuke Koya, Robert C. Ritter, Friedbert Weiss, Nobuyoshi Suto   +16 more
openalex   +1 more source

The Economics of Crime: Investigating the Drugs-Crime Channel [PDF]

The rising trends both in drug addiction and crime rates are of major public concern in Germany. Surprisingly, the economic theory of crime seems to ignore the drugs-crime nexus, whereas the criminological literature considers illicit drug use a main ...
Entorf, Horst, Winker, Peter
core  

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study

BMC Health Services Research
Background Opioid agonist treatment (OAT) for patients with opioid use disorder (OUD) has a convincing evidence base, although variable retention rates suggest that it may not be beneficial for all.
Lars Henrik Myklebust, Desiree Eide, Espen A. Arnevik, Omid Dadras, Silvana De Pirro, Rune Ellefsen, Lars T. Fadnes, Morten Hesse, Timo L. Kvamme, Francesca Melis, Ann Oldervoll, Birgitte Thylstrup, Linda E.C. Wusthoff, Thomas Clausen   +13 more
doaj   +1 more source

Figure S6 from Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma

, 2023
Aayoung Hong, Gatien Moriceau, Lu Sun, Shirley H. Lomeli, Marco Piva, Robert Damoiseaux, Sheri L. Holmen, Norman E. Sharpless, Willy Hugo, Roger S. Lo   +9 more
openalex   +1 more source

SEARC Mathematical Modeling of Drug Addiction in South Sulawesi Province [PDF]

, 2023
Dian R Magfirah, Wahidah Sanusi, Syafruddin Side, Rahmat Syam, M R Y S A Andi Pandjajangi   +4 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Pathways Relating the Neurobiology of Attachment to Drug Addiction [PDF]

, 2019
Lane Strathearn, Carol E. Mertens, Linda C. Mayes, Helena J. V. Rutherford, Purva Rajhans, Guifeng Xu, Marc N. Potenza, Sohye Kim   +7 more
openalex   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source